Mesoblast Stock (NASDAQ: MESO) stock price, news, charts, stock research, profile.
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Other companies in Mesoblast’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Upstream Bio (NASDAQ:UPB).
Mesoblast has a consensus price target of $8.17.
The stock price for Mesoblast (NASDAQ: MESO) is $9.9 last updated November 22, 2024 at 9:28 AM EST.
There are no upcoming dividends for Mesoblast.
Mesoblast’s FY earnings are confirmed for Wednesday, August 28, 2024.
There is no upcoming split for Mesoblast.
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.